RESEARCH-USE BIOSIMILAR ANTIBODY

Upanovimab

Monoclonal antibody · IgG1

SARS-CoV-2 Spike RBDIgG1RUO

Upanovimab (SCTA01) is a monoclonal antibody that targets the SARS-CoV-2 S protein.

TARGETSARS-CoV-2 Spike RBD
YMonoclonal antibody
CATALOGSC-BS-063
CATALOG NUMBERSC-BS-063
MOLECULAR WEIGHTApprox. 145.633 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Upanovimab (SCTA01) is a monoclonal antibody that targets the SARS-CoV-2 S protein.

Upanovimab is a recombinant research-use antibody directed against SARS-CoV-2 Spike RBD.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Upanovimab | StellaCyte